Methicillin-resistant staphylococcus aureus in nepal

9Citations
Citations of this article
317Readers
Mendeley users who have this article in their library.

Abstract

Staphylococcus aureus is both a frequent commensal and a leading cause of endocarditis, bacteremia, osteomyelitis and skin and soft tissue infections and device-related infections. We performed this minireview to summarize the prevalence of Staphylococcus aureus among clinical samples and estimate the proportion of methicillin-resistant Staphylococcus aureus. The prevalence of Staphylococcus aureus among clinical isolates in Nepal is 34.5%. On average, the proportion of multi-drug resistance in Staphylococcus aureus is 57.1%. Methicillin-resistant Staphylococcus aureus accounts for a total of 41.7%. Inducible clindamycin resistance was detected in about 35% of the isolates. A regular antimicrobial resistance surveillance mechanism is necessary to mitigate the development of resistance among organisms and further spread of superbugs like methicillin-resistance Staphylococcus aureus.

Cite

CITATION STYLE

APA

Shrestha, L. B., Syangtan, G., Basnet, A., Acharya, K. P., Chand, A. B., & Pokhrel, K. (2021, May 1). Methicillin-resistant staphylococcus aureus in nepal. Journal of the Nepal Medical Association. Nepal Medical Association. https://doi.org/10.31729/JNMA.6251

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free